BKS Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $20K | Hold |
15,000
| – | – | 0.01% | 207 |
|
|
2018
Q4 | $14K | Sell |
15,000
-2,145
| -13% | -$2K | 0.01% | 196 |
|
|
2018
Q3 | $35K | Hold |
17,145
| – | – | 0.01% | 217 |
|
|
2018
Q2 | $31K | Hold |
17,145
| – | – | 0.01% | 231 |
|
|
2018
Q1 | $40K | Buy |
+17,145
| New | +$40K | 0.01% | 214 |
|
|
2017
Q4 | – | Sell |
-11,430
| Closed | -$28K | – | 217 |
|
|
2017
Q3 | $28K | Hold |
11,430
| – | – | 0.01% | 209 |
|
|
2017
Q2 | $32K | Hold |
11,430
| – | – | 0.01% | 203 |
|
|
2017
Q1 | $35K | Hold |
11,430
| – | – | 0.02% | 194 |
|
|
2016
Q4 | $36K | Hold |
11,430
| – | – | 0.02% | 182 |
|
|
2016
Q3 | $39K | Hold |
11,430
| – | – | 0.02% | 235 |
|
|
2016
Q2 | $26K | Hold |
11,430
| – | – | 0.01% | 174 |
|
|
2016
Q1 | $29K | Sell |
11,430
-960
| -8% | -$2.44K | 0.02% | 167 |
|
|
2015
Q4 | $41K | Buy |
+12,390
| New | +$41K | 0.02% | 152 |
|